Skip to main content

Influenza Vaccine Market Growth Opportunities, Key Driving Factors, Market Scenario and Forecast to 2027



This report is based on a comprehensive research of the worldwide influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the worldwide influenza vaccines market. The report provides historical market data for 2013 – 2019, and forecasts from 2020 until 2027. A comprehensive analysis has been done on market share with the percentage of all the segments. Read More

@SanofiPasteur,@GlaxoSmithKline,@Seqirus,@CSL Limited,@AstraZeneca,@Mylan,@GammaVaccines,
@Hualan,@ShanghaiInstitute,@BioDiem,@Novavax,@BiondVax,
@Medicago,@Moderna,@Pneumagen,@Daiichi–Sankyo,@Altimmune,@FluGen,@Imutex



Comments

Popular posts from this blog

At 18% CAGR, U S NIPT Test Market Size is Expected to Exhibit US$ 2 2 b...

GCC Countries will Attract 7.7 Million Indian travelers by 2025

  According to the DPI Research new growth forecast report titled  Impact of the COVID-19 Outbreak on Indian Outbound Travelers Traffic and Market Revenue to the GCC Countries   Value is set to earn USD 12 billion by 2025. It is forecasted that GCC countries will attract nearly 7.7 Million Indian travelers and generated more than US$ 12 billion market revenues by 2025. The objective of this market research report is to provide an overview of the development of the Indian outbound travelers traffic to the major continents and to give an insight into the Indian outbound travelers’ traffic and market revenue to the GCC countries. The GCC Countries which we covered in the report are UAE, Saudi Arabia, Oman, Qatar, Kuwait, and Bahrain. The database of the following report is defined as follows: Total India Outbound Travelers Visitation & Forecast – By Continents (2018 – 2025) India Outbound Travelers Visitation to the GCC Countries & Forecast (2018 – 2025) India Outbound Travelers M

Global Influenza Vaccines Market Prospects and Growth Potential

  The global influenza vaccines marke t size was valued at USD 7.8 Billion in 2023 and is likely to reach USD 13.7 Billion in 2032, expanding at a CAGR 7.2% during the forecast period.